Deals

Deals  ·  Weekly Digest 30 Nov to 06 Dec 2024
GSK goes East again, snagging option on preclinical DualityBio ADC for $30M

Weekly Digest – December 2024 Weekly Digest – December 2024 04 Dec 2024: GSK goes East again, snagging option on preclinical DualityBio ADC for $30M GSK has entered into a deal with Duality Biologics to license a preclinical antibody-drug conjugate […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest 30 Nov to 06 Dec 2024
Gilead and Tubulis Enter Into Exclusive Option and License Agreement to Develop ADC Candidate for Select Solid Tumor Target

Weekly Digest – November 2024 Weekly Digest – November 2024 25 Nov 2024: Adcendo raises $135m as ADC funding frenzy continues Adcendo raised $135 million in funding to advance its portfolio of first-in-class ADCs into clinical trials Company’s ADC candidate, […]

by Sandhya Ramalingam

Continue Reading